Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Effect on Insulin Sensitivity in T2DM
NCT01356381Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Apr 2011; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01356381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356381.